PROPERTIES OF ANTIVIRAL AGENTS: First of Two Parts
- 1 September 1984
- journal article
- Published by Elsevier in The Lancet
- Vol. 324 (8401), 503-506
- https://doi.org/10.1016/s0140-6736(84)92576-5
Abstract
No abstract availableThis publication has 61 references indexed in Scilit:
- Early Vidarabine Therapy to Control the Complications of Herpes Zoster in Immunosuppressed PatientsNew England Journal of Medicine, 1982
- Fatal vidarabine toxicity in a patient with normal renal functionJAMA, 1981
- Adenine Arabinoside and Allopurinol — Possible Adverse Drug InteractionNew England Journal of Medicine, 1981
- VidarabineDrugs, 1980
- Antiherpesvirus Activity in Human Sera and Urines after Administration of Adenine ArabinosideJCI Insight, 1978
- RELATIVE POTENCIES OF ANTI‐HERPES COMPOUNDSAnnals of the New York Academy of Sciences, 1977
- Toxicity of Adenine Arabinoside in HumansThe Journal of Infectious Diseases, 1976
- Susceptibility of Herpesviruses to Three Nucleoside Analogues and Their Combinations and Enhancement of the Antiviral Effect at Acid pHThe Journal of Infectious Diseases, 1974
- Concentrations of Idoxuridine in Serum, Urine, and Cerebrospinal Fluid of Patients with Suspected Diagnoses of Herpesvirus hominis EncephalitisJCI Insight, 1972
- THE EPIDEMIOLOGY AND CHEMOTHERAPY OF HERPES SIMPLEX KERATITIS AND HERPES SIMPLEX SKIN INFECTIONSAnnals of the New York Academy of Sciences, 1965